Tango Therapeutics (TNGX) Cash from Operations Growth (1y) (2021 - 2026)
Tango Therapeutics (TNGX) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Tango Therapeutics |
4.05 Bn |
3.67 Bn |
- |
-6.39% |
| Date | Value |
|---|
| Mar 31, 2026 |
-6.39% |
| Dec 31, 2025 |
18.91% |
| Sep 30, 2025 |
7.30% |
| Jun 30, 2025 |
-54.70% |
| Mar 31, 2025 |
-10.14% |
| Dec 31, 2024 |
-33.42% |
| Sep 30, 2024 |
-7.24% |
| Jun 30, 2024 |
3.54% |
| Mar 31, 2024 |
-8.45% |
| Dec 31, 2023 |
2.83% |
| Sep 30, 2023 |
-58.76% |
| Jun 30, 2023 |
22.40% |
| Mar 31, 2023 |
-17.67% |
| Dec 31, 2022 |
-67.23% |
| Sep 30, 2022 |
8.76% |
| Jun 30, 2022 |
-319.50% |
| Mar 31, 2022 |
-117.92% |
| Dec 31, 2021 |
-5,062.13% |
| Sep 30, 2021 |
-23,974.55% |
| Jun 30, 2021 |
-23,493,650.00% |
